Condition:   Infections With Soil-Transmitted Helminths (STH)
Intervention:   Drug: Albendazole
Sponsors:   University Ghent;   World Health Organization;   Department of Virology, Parasitology and Immunology,Ghent University, Faculty of Veterinary Medicine,Belgium;   Department of Neglected Tropical Diseases, World Health Organization, Geneva, Switzerland;   Department of Microbiology, Immunology, and Tropical Medicine, George Washington University Medical Center, Washington DC, USA;   Division of Livestock Industries, Commonwealth Scientific and Industrial Research Organisation, Brisbane, Australia;   School of Biology, University of Nottingham, Notthingham, UK;   Queensland Institute for Medical Research, University of Queensland, Herston, Australia
Active, not recruiting - verified March 2010

Condition:   Malaria
Intervention:   Other: PfSPZ (Pf sporozoites)
Sponsors:   Sanaria Inc.;   The Netherlands: Radboud University Nijmegen Medical Center
Not yet recruiting - verified March 2010

Condition:   Infections
Intervention:   Behavioral: Health Education Intervention
Sponsor:   McGill University Health Center
Not yet recruiting - verified March 2010

Conditions:   Malaria;   Pregnancy
Intervention:   Drug: Mefloquine Artesunate
Sponsor:   Centers for Disease Control and Prevention
Not yet recruiting - verified March 2010

Condition:   P. Falciparum Malaria
Interventions:   Drug: artemether-lumefantrine;   Drug: Dihydroartemisinin-piperaquine
Sponsor:   Centers for Disease Control and Prevention
Not yet recruiting - verified March 2010

Condition:   Malaria
Interventions:   Drug: Artemether-Lumefantrine;   Drug: Mefloquine- Artesunate
Sponsor:   Centers for Disease Control and Prevention
Not yet recruiting - verified March 2010

Condition:   Leishmaniasis, Cutaneous
Interventions:   Drug: WR 279,396 (15% paromomycin + 0.5% gentamicin topical cream);   Drug: Paromomycin Alone Cream (15% paromomycin topical cream)
Sponsor:   U.S. Army Office of the Surgeon General
Not yet recruiting - verified March 2010

Condition:   Malaria, Vivax
Intervention:   Biological: Sporozoite Challenge Model for Plasmodium vivax in Humans
Sponsors:   Malaria Vaccine and Drug Development Center;   Ministerio de la Protección Social, Colombia.
Completed - verified December 2006

Condition:   Malaria
Intervention:   Biological: Immunization with P. vivax irradiated sporozoites
Sponsors:   Malaria Vaccine and Drug Development Center;   National Heart, Lung, and Blood Institute (NHLBI);   Asoclinic Laboratorio de Inmunología
Not yet recruiting - verified March 2010

Condition:   Malaria, Vivax
Interventions:   Drug: Peptides (N,R&C) formulated in Montanide ISA 720;   Drug: Peptides (N,R&C) formulated in Montanide ISA 51;   Drug: Peptides (N,R&C) formulated in Montanide ISA 720;   Drug: Peptides (N,R&C) formulated in Montanide ISA 51;   Other: Placebo
Sponsors:   Malaria Vaccine and Drug Development Center;   Centro médico Imbanaco;   Asoclinic Laboratorio de Inmunología
Completed - verified March 2010

Condition:   Malaria in Pregnancy
Interventions:   Other: Intermittent screening and treatment of malaria in pregnancy (IST);   Other: SP-IPTp
Sponsors:   London School of Hygiene and Tropical Medicine;   Medical Research and Training Centre, Mali;   Université de Ouagadougou, Burkina Faso;   Medical Research Council Laboratories, Gambia;   Navrongo Health Research Centre, Ghana;   Liverpool School of Tropical Medicine
Not yet recruiting - verified March 2010

Condition:   Vivax Malaria
Intervention:   Drug: Primaquine
Sponsors:   University of Oxford;   Mahidol University
Recruiting - verified February 2010

Condition:   Vivax Malaria
Interventions:   Drug: Artesunate;   Drug: Chloroquine;   Drug: Chloroquine/Primaquine
Sponsors:   University of Oxford;   Mahidol University
Not yet recruiting - verified February 2010

Condition:   Malaria
Interventions:   Drug: Dihydroartemisinin- piperaquine;   Drug: artemether- lumefantrine
Sponsors:   University of Khartoum;   Southeast University, China
Recruiting - verified February 2010